LUNGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Pulmonx Corp

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026

$1.75−0.03 (-1.69%)

Close on Oct 19, 2026

Market cap: $74.32M
P/E (TTM): –
Dividend yield: –

Pulmonx Corp cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31
Stock-Based Compensation	21	23	22	16	11	3.20	0.36	0.37
Deferred Income Taxes	-0.02	-0.02	0.03	0.06	-0.02	0.02	-0.01	-0.20
Change in Accounts Receivable	1.08	-1.31	-3.10	-2.19	-2.43	1.46	-2.52	-0.26
Change in Inventory	-0.77	-0.23	0.92	-3.64	-6.46	-5.05	-2.61	-1.25
Change in Accounts Payable	0.27	2.28	-0.35	0.25	0.09	0.59	0.52	-0.65
Change in Unearned Revenue	-0.12	0.03	-0.02	-0.04	0.09	-0.11	0.03	-0.04
Operating Cash Flow	-32	-32	-38	-45	-41	-31	-21	-18
Capital Expenditures	-0.45	-1.45	-0.81	-1.32	-3.67	-0.91	-0.72	-0.32
Sale of Property, Plant & Equipment	–	–	–	–	–	0	0	0.02
Purchase of Investments	-5.65	-28	-46	-47	-53	0	-21	0
Investing Cash Flow	30	17	-2.01	-4.23	-46	13	-14	0.20
Share Repurchases	–	–	0	-0.03	-0.03	-0.02	-0.01	0
Debt Issued	–	0	20	0	–	–	–	–
Financing Cash Flow	0.83	1.36	21	2.42	4.46	235	46	12
Foreign Exchange Rate Adjustments	-0.09	0.08	0.03	0.15	0.11	0.13	0.02	0.15
Net Change in Cash	-1.15	-13	-18	-47	-83	217	11	-5.93
Free Cash Flow	-33	-33	-38	-46	-45	-32	-21	-19
Income Taxes Paid	0.47	0.56	0.50	0.40	0.32	0.26	0.20	0.23
Interest Paid	3.11	3.48	2.98	0.85	0.72	3.06	1.40	1.36

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 77.1%
Operating margin: -53.0%
Net margin: -55.0%
Return on equity, FY2025: -77.2%

Financial strength

Current ratio: 4.32
Debt to equity: 0.96
Debt to assets: 32.7%
Cash to current liabilities: 273.7%

Valuation

P/E ratio: –
Price to sales: 0.85
Price to book: 1.90
Dividend yield: –